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Clinical decision support interventions are typically heterogeneous in nature, making it difﬁcult to iden-
tify why some interventions succeed while others do not. One approach to identify factors important to
the success of health information systems is the use of meta-regression techniques, in which potential
explanatory factors are correlated with the outcome of interest. This approach, however, can result in
misleading conclusions due to several issues. In this manuscript, we present a cautionary case study in
the context of clinical decision support systems to illustrate the limitations of this type of analysis. We
then discuss implications and recommendations for future work aimed at identifying success factors of
medical informatics interventions. In particular, we identify the need for head-to-head trials in which
the importance of system features is directly evaluated in a prospective manner.
 2015 Elsevier Inc. All rights reserved.1. Introduction Kawamoto et al. [1] Notably, Roshanov et al. [6] found that adviceClinical decision support (CDS) interventions are typically
heterogeneous in nature, making it difﬁcult to identify why some
interventions succeed while others do not [1]. In recent years,
investigators have sought to address this difﬁculty through the
use of meta-regression techniques [1–6]. In this approach, investi-
gators apply regression techniques to identify features of informa-
tion systems (e.g., workﬂow integration or patient engagement)
that are signiﬁcantly associated with desired outcomes. However,
meta-regression analysis has recognized limitations [7–9]. A par-
ticularly important limitation is the observational nature of this
type of analysis. As such, causal relationships cannot be illumi-
nated by this approach alone. To illustrate why care should be
taken when performing or interpreting this type of analysis, this
manuscript provides a cautionary case study in the context of
CDS evaluation.
In 2013, the British Medical Journal published a meta-regression
analysis by Roshanov et al. [6] of randomized controlled trials
(RCTs) of CDS systems. The study sought to identify features asso-
ciated with effective systems and resulted in conclusions that dif-
fered signiﬁcantly from similar studies, including a prior
meta-regression analysis in the British Medical Journal bygiven automatically in workﬂow was not signiﬁcantly associated
with system success in their initial model. As a result, this feature
was removed from their ﬁnal model.
This particular ﬁnding was unexpected, as it differed signiﬁ-
cantly from ﬁndings suggested by previous reviews addressing
clinical decision support [1,2,4,10–12]. Moreover, RCTs that
directly evaluated the importance of this feature have found auto-
matic provision to be important [13,14]. Speciﬁcally, within the
clinical context of hyperlipidemia management, van Wyk et al.
[14] compared alerts provided automatically to physicians within
an EHR versus on-demand CDS which had to be proactively
accessed by physicians within the same EHR. In this cluster RCT
involving 38 Dutch general practices and 87,886 patients, 65% of
the patients requiring screening were screened in the automatic
CDS group, as compared to 35% in the on-demand CDS group
(adjust relative risk 1.40; 95% conﬁdence interval [CI], 1.08 to
1.81) [14]. In another RCT directly evaluating the importance of
providing CDS automatically, Scheepers-Hoeks et al. [13] com-
pared alerts provided automatically to physicians within an EHR
versus the same information provided on-demand in the EHR. In
this RCT, which was conducted in an intensive care unit (ICU)
regarding 13 locally developed clinical rules, compliance with the
CDS recommendations was 41% in the automatic alerting group,
versus 19% in the on-demand EHR group (p < 0.0001) [13]. Such
ﬁndings from head-to-head RCTs must be considered very seri-
ously, as they directly evaluate causative relationships between a
CDS feature and system impact, rather than merely correlation as
in the case of a meta-regression analysis.
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meta-regression analysis by Roshanov et al. [6] and these prior
studies on the topic, we sought to discover an explanation for these
ﬁndings. Here, we describe our ﬁndings and discuss implications




Based on results from other studies identifying the importance
of automatic CDS provision, as well as our initial review of the
source data set provided in Appendix of the Roshanov et al. [6]
article, we suspected that the differences between the two
meta-regression analyses were more likely due to discrepancies
in the source data rather than differences in statistical analysis
methods. In particular, in the meta-regression analysis by
Kawamoto et al. [1], CDS systems that automatically provided their
advice had a success rate of 75%, versus a success rate of 0% for sys-
tems that did not (difference = 75%). In contrast, in the systematic
review by Roshanov et al. [6], the difference in success rate was
only 60% versus 54% (difference = 6%).
In examining potential reasons for the differences in the source
data set, we found that the differences appeared to stem from dis-
crepancies in the determination of whether speciﬁc explanatory
features were present or absent in a given CDS system. In particu-
lar, Roshanov et al. [6] appeared to consider many CDS systems
whose use was required by a study protocol to not be automati-
cally provided as a part of clinician workﬂow, whereas the end
result would be the same: clinicians would always be exposed to
the intervention.
2.2. Hypothesis
In our opinion, mandated, protocol-driven use of a CDS system
is functionally equivalent to automatic provision of CDS. Therefore,
we hypothesized that the results would be more consistent with
prior studies if we considered protocol-driven provision of CDS
to constitute automatic provision. To test this hypothesis, we
repeated the same statistical analysis conducted by Roshanov
et al. using this updated deﬁnition of automatic CDS provision.
2.3. Dataset
We used the dataset of 162 randomized controlled trials of CDS
systems identiﬁed by Roshanov et al. [6]
2.4. Outcome and explanatory variables
As in the original systematic review, ‘‘effective’’ systems were
deﬁned as those systems that improved primary (or 50% of sec-
ondary) reported outcomes of process of care or patient health.
For the outcome measure, we maintained the determinations
made by Roshanov et al. [6] As in the original study, we focused
on six potential explanatory variables for CDS outcomes: auto-
matic provision of CDS, development by authors, feedback at the
time of care, advice presented in electronic charting or order entry,
advice for patient, and requires reason for override.
2.5. Feature reanalysis
We re-assessed each source study for the presence of ‘‘auto-
matic provision of CDS’’ using an updated deﬁnition that included
cases where use of the CDS was mandated by protocol. If both theintervention and control groups involved use of a clinical informa-
tion management tool (e.g., EHR or computerized provider order
entry [CPOE] system), the CDS was considered to be automatically
provided if exposure to the CDS did not require any end-user initia-
tive beyond simply using the base information management tool. If
it was unclear whether the CDS was provided automatically, we
deferred to the determination made by Roshanov et al. [6].
In addition, we sought to improve the quality of the data set for
the reanalysis by completing incomplete explanatory variable clas-
siﬁcations. Speciﬁcally, we reanalyzed the ‘‘author developed’’ and
‘‘feedback at time of care’’ features for trials where Roshanov et al.
[6] were unable to determine the presence or absence of those fea-
tures. We considered a CDS intervention to have been developed
by the authors if the study stated or implied that one or more of
the study authors were involved in the development of the system.
If the authors developed the underlying clinical algorithm or
knowledge base used in a CDS system, we also considered the
CDS intervention to have been developed by the authors. We con-
sidered a CDS intervention to have delivered feedback at the time
of care if the CDS was provided to the clinician while the clinician
was with the patient in question for the purposes of clinical care. If
we were unable to make a determination based on the manuscript,
we attempted to make direct contact with the authors to make
these determinations. If it was unclear whether the CDS system
was author developed or provided feedback at the time of care,
and if we were unable to make contact with the authors, we main-
tained the unknown status.
The presence or absence of features was determined through
the consensus of four of the authors (CLF, MZ, BMW, and KK).
These reviewers consisted of two physician informaticists (KK
and CLF), one nurse informaticist (MZ), and one additional health
informaticist (BMW).
2.6. Exclusions
We excluded studies where the intervention arm with the CDS
system was disadvantaged in a signiﬁcant way compared to the
control arm. Example disadvantages included care delivery by
practitioners with signiﬁcantly less training (e.g., nurse versus
physician), or the removal of a key diagnostic resource.
2.7. Statistical analysis
The original data set and statistical analysis ﬁle used in the
manuscript by Roshanov et al. [6] was kindly provided by the
authors. Using this data set and analysis ﬁle, the primary analysis
from the original study was replicated. Following this replication
of ﬁndings, the data set was modiﬁed as described above, and
the primary analysis was repeated with the updated data. In brief,
the primary analysis as developed by Roshanov et al. [6], and repli-
cated here without modiﬁcation, consisted of the following: (i) the
selection of explanatory variables for inclusion in the ﬁnal primary
model, with variables selected if they were associated with the
study outcomes with a p < 0.1; and (ii) the development of a ﬁnal
model to explain the study outcomes using these selected explana-
tory variables. For these analyses, Firth’s proﬁle penalized likeli-
hood method was used as in the original study. All statistical
analyses were performed using Stata 13.1 [15].3. Results
3.1. Feature reanalysis
In the reanalysis, we revised the ‘‘automatic provisioning’’ fea-
ture for 46 (28%) of the original 162 studies in the data set. Of these
Table 1
Meta-regression results. Figures are odds ratios (95% conﬁdence interval), P value.
Original study Reanalysis
Initial model (148 trials) (159 trials)
Developed by authors 3.52 (1.34–9.27), 0.01 3.87 (1.55–9.63), 0.003
Advice automatically in workﬂow 1.48 (0.62–3.52), 0.38 2.92 (0.82–10.38), 0.088
Advice at time of care 0.61 (0.21–1.77), 0.35 0.88 (0.32–2.41), 0.8
Advice presented in electronic charting or order entry 0.33 (0.14–0.76), 0.01 0.37 (0.18–0.79), 0.009
Provides advice for patients 2.54 (0.98–6.57), 0.05 2.58 (1.00–6.66), 0.042
Requires reason for override 10.69 (1.87–61.02), 0.001 7.06 (1.78–28.03), 0.001
Final model (150 trials) (159 trials)
Developed by authors 4.35 (1.66–11.44), 0.002 3.96 (1.59–9.86), 0.002
Advice automatically in workﬂow N/A 3.03 (0.86–10.68), 0.078
Advice presented in electronic charting or order entry 0.37 (0.17–0.80), 0.01 0.36 (0.17–0.77), 0.007
Provides advice for patients 2.77 (1.07–7.17), 0.03 2.62 (1.02–6.78), 0.038
Requires reason for override 11.23 (1.98–63.72), <0.001 7.25 (1.82–28.89), <0.001
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feature.
In the original paper, 14 studies did not have a determination
for either the ‘‘developed by authors’’ or ‘‘feedback at time of care’’
features and thus were not included in the original primary analy-
sis. Of these 14 studies with missing data, we were able to com-
plete the data in 13 of the studies.
In total, these revisions were applied to 50 (31%) of the studies
in the data set. The Supplemental online Appendix provides details
regarding these revisions.
3.2. Exclusions
We excluded two studies where the CDS intervention arm was
signiﬁcantly disadvantaged compared to the control arm. In one
study, the performance of nurses using a CDS system was com-
pared to that of physicians who did not use the CDS system [16].
In the other excluded study, in which the outcome of interest
was the diagnosis of acute small bowel obstruction, the CDS inter-
vention arm did not have access to contrast radiography, a key
diagnostic resource available in the control arm [17].
3.3. Meta-regression analysis results
Table 1 summarizes the ﬁndings from the reanalysis. As shown
in the table, automatic provision of CDS was associated with study
outcome with a p < 0.1 in the initial model. Therefore, this feature
was eligible for inclusion in the ﬁnal model. This ﬁnding was in
contrast to the results from the original study, where the signiﬁ-
cance of the association was p = 0.38, such that this feature was
excluded from the ﬁnal model. The end results for the other fea-
tures remained the same; ‘‘advice at time of care’’ did not meet
inclusion criteria for the ﬁnal model, while the remaining features
were included.
In the ﬁnal model, ‘‘automatic provision of CDS’’ was found to
be nearly statistically signiﬁcant (p = 0.078). The remaining fea-
tures that were identiﬁed as being important in the original study
remained so in the ﬁnal model.
4. Discussion
4.1. Summary of ﬁndings
In their original study, Roshanov et al. [6] concluded that auto-
matic provisioning of CDS was not an important factor in deter-
mining the effectiveness of CDS systems. In contrast, automatic
provisioning of CDS met criteria for inclusion in our ﬁnal model
and approached statistical signiﬁcance in the ﬁnal analysis(p < 0.1). As noted in the introduction, our ﬁndings align with the
conclusions from RCTs that have directly evaluated the importance
of this feature, which have found that automatic provision of CDS is
a critical factor for determining the effectiveness of CDS systems
[13,14].
4.2. Implications
Beyond the obvious implications related to automatic provision
of CDS, this reanalysis serves to highlight potential limitations of
meta-regression techniques. One such limitation is that
meta-regression results can hinge upon how explanatory factors
are deﬁned and subsequently abstracted. In this reanalysis, we
believe our deﬁnition of automatic provisioning more accurately
reﬂects the reality of automatically providing CDS within provider
workﬂow. A clear implication, then, is that meta-regression analy-
ses are highly dependent on the exact deﬁnitions used for explana-
tory factors and the reliability of their abstraction.
Another implication of this study is that a meta-regression anal-
ysis can beneﬁt from secondary reanalysis by an independent
group. While it is assumed that different groups would reach the
same conclusions from the same source literature, the only empir-
ical way to validate this assumption is for the reanalysis to actually
be conducted. Of note, a conﬁrmatory reanalysis may be difﬁcult to
publish, similar to how a negative study can be difﬁcult to publish.
Consequently, an important challenge will be identifying how to
motivate and reward the conduct of such reanalyses.
Furthermore, the most critical limitation of meta-regression
techniques is the inability to evaluate for causative relationships
between variables. As such, we believe another vital implication
of our ﬁndings is that more RCTs that directly evaluate the impor-
tance of CDS features are needed. Additionally, given the
multi-faceted nature of CDS interventions, researchers should con-
sider the use of modern trial designs such as adaptive and prag-
matic trials that may allow for more appropriate evaluations of
interventions within complex sociotechnical settings. Considering
the inherent challenges of inferring causality or demonstrating
real-world effectiveness frommeta-regression analyses, direct trial
evidence will be invaluable in guiding future CDS implementations.
Finally, an important implication of our ﬁndings is that
meta-regression analyses can potentially lead to erroneous conclu-
sions. Therefore, caution should be exercised in making decisions
based on the ﬁndings of meta-regression analyses alone.
4.3. Recommendations
Given the perils of meta-regression as described in this case
study, we recommend the following moving forward:
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tures of CDS systems in published evaluations in order to facil-
itate effective explanatory factor abstraction.
 Give careful consideration to the deﬁnition and abstraction
of potential explanatory factors when conducting meta-
regression analyses.
 Consider meta-regression as an interim step for generating
hypotheses for the importance of speciﬁc health information
system features. Any ﬁndings should be validated through
actual implementation experience and clinical trials.
 Identify mechanisms for promoting reanalyses of meta-
regression studies. For example, a journal may devote a special
issue focused on replication studies, including for meta-
regression analyses.
 Conduct more trials designed to directly evaluate the impor-
tance of speciﬁc CDS features. Once available, generally defer
to the results of direct trials rather than regression analyses.
5. Conclusion
Given the limitations of meta-regression analyses, further
research – particularly head to head trials evaluating the effective-
ness of CDS system features – is clearly warranted.
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